Meticulous Research®, a premier global market research firm, has released a new report titled "Rapid Diagnostic Kits Market for Indian Ocean Region Countries by Product (Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious Diseases, Cardiac, Urinalysis, Cholesterol), End User (Hospitals, Diagnostic Labs) — Forecast to 2029." This publication projects that the rapid diagnostics kits market in the Indian Ocean region will achieve a compound annual growth rate (CAGR) of 1.6% from 2022 to 2029, culminating in an estimated value of $1.75 billion by the end of the forecast period.
The report segments the Rapid Diagnostics Kits Market for Indian Ocean Region Countries by Product (Professional Kits, OTC Kits), Platform (Immunoassays, Molecular Detection Tests, and Other Rapid Diagnostic Platforms), Application (including but not limited to Blood Glucose Testing, Infectious Diseases Testing, Urinalysis, and Cholesterol Testing), and End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care/Self-testing, and Others).
Key Findings from the Report:
Product Segment: The professional kits segment is anticipated to dominate the market due to the preference for PoC testing and advancements in rapid diagnostics.
Platform Segment: Immunoassays are expected to hold the largest share, driven by high prevalence rates of chronic and infectious diseases and the benefits of rapid immunoassay tests.
Application Segment: Infectious diseases testing is projected to be the leading application area, given the urgent need for timely diagnoses to prevent widespread outbreaks.
End User Segment: Hospitals & clinics are likely to be the primary adopters of rapid diagnostic kits, reflecting a preference for primary care settings in the region.
The comprehensive report encompasses an in-depth analysis of the market across specific geographies, including France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles. India is anticipated to exhibit the highest growth trajectory during the forecast period, attributed to increasing hospitalizations, a growing elderly population, and enhanced healthcare accessibility and expenditure.
Leading companies in the rapid diagnostic kits market for Indian Ocean region countries include Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian